1)Sustained-release chemotherapy缓释化疗
1.Sustained-release chemotherapy with mitomycin fibrin gel for gastrointestinal poorly differentiated adenocarcinoma丝裂霉素纤维蛋白凝胶缓释化疗胃肠道低分化腺癌的临床研究
英文短句/例句
1.Experimental Study on Cerebral Glioma Treated by Quercetin Through Sustained-release Chemotherapy;槲皮素缓释化疗治疗脑胶质瘤的实验研究
2.Experimental Research on Sustained-released Intraperitoneal Chemotherapy with 5-fluorouracil;5-氟尿嘧啶腹腔内缓释化疗的实验研究
3.The Primary Research of Chitosan for the Local Sustained-releasing Chemotherapeutic Carrier in the Rat Brain;壳聚糖颅内局部缓释化疗载体的初步研究
4.Use of Regional Sustained-Release Chemotherapy in Colorectal Carcinoma During Operation区域性缓释化疗在结直肠癌术中的应用
5.Radiofrequency ablation combined with implantation of slow-release seeds in treatment of colorectal hepatic metastic carcinoma射频消融联合缓释化疗粒子植入治疗结直肠癌肝转移
6.Sustained-release chemotherapy with mitomycin fibrin gel for gastrointestinal poorly differentiated adenocarcinoma丝裂霉素纤维蛋白凝胶缓释化疗胃肠道低分化腺癌的临床研究
7.Effects and Mechanisms of NCPP Combined with Slow Intra-tumor Release of Drugs on Tumors in MiceNCPP联合瘤内缓释化疗对小鼠肿瘤的抑制作用和机制探讨
8.Implantation of ~(125)I particles plus 5-FU slow-release particles for forty-two patients with advanced pancreatic cancer~(125)I粒子联合5-氟尿嘧啶缓释化疗粒子植入治疗晚期胰腺癌42例疗效观察
9.Experimental and Clinical Research on Sustained-release 5-FU Microparticle Interstitial Chemotherapy of Primary Hepatic Cancer;肝癌5-FU缓释微粒间质化疗的实验及临床研究
10.The Investigation of Slow-release PLGA-Gemcitabine Microsphere in Treatmentment of Pancreatic Cancer;PLGA-吉西他滨缓释微球间质化疗应用于胰腺癌治疗的实验研究
11.A Comparison between Venlafaxine XR and Chlorimipramine in the Treatment of Somatization Disorder文拉法辛缓释剂与氯米帕明治疗躯体化障碍的疗效比较
12.Evaluation of pre-operation neoadjuvant chemotherapy with 5-Fluorouracil Sustained Release For Implant injected in rectal submucosal in the patients with colorectal cancer;直肠粘膜下植入5-Fu缓释剂对大肠癌新辅助化疗的研究
13.The Short-term Clinical Observation of Intrapertoneal Chemotherapy with Sustained-release 5-Fluorouracil in Operation in Advanced Gastric Cancer (30 Cases Reported)30例进展期胃癌术中缓释5-氟尿嘧啶腹腔化疗的近期临床观察
14.Efficacy of Intraperitoneally Injected Epirubicin-loaded Poly(D,L)-lactic Acid Microspheres Alone or Combined with Free Epirubicin in Treating Hepatocellular Carcinoma in Mice单用表阿霉素缓释剂及联合表阿霉素游离剂腹腔化疗治疗肝癌的疗效
15.Effect of Rhubarb Buccal Film on Experimental Periodontitis in Rat大黄缓释膜治疗实验性牙周炎的研究
16.Clinical observation on the therapeutic effect of sustained release tablets of magnesium valproate in 88 cases of epileptic seizure丙戊酸镁缓释片治疗癫痫的临床观察
17.Combined Fluorouracil or Cisplatin Sustained Release Seed with ~(125)I Particle to Treat Lung Cancer缓释氟尿嘧啶与缓释顺铂粒子联合~(125)I粒子治疗肺癌
18.The Clinical Effects Evaluation of Shuanghuangbu Sustained-release Preparation in Chronic Periodontitis;双黄补缓释药条治疗慢性牙周炎临床疗效评估
相关短句/例句
chemotherapeutic slow-release ion化疗缓释粒子
1.Objective: To evaluate the therapeutic efficacy and side effect of endoscopic implantation with chemotherapeutic slow-release ion for the treatment of gastrointestinal malignant tumors.目的初步评价化疗缓释粒子肿瘤部位植入治疗胃肠恶性肿瘤的临床疗效和不良反应。
3)regional extended release Chemotherapy区域缓释化疗
4)Fluorouracil sustained release缓释化疗粒子
5)intraperitoneal sustained-realesed chemotherapy腹腔内缓释化疗
1.To evaluate the preponderance of intraperitoneal sustained-realesed chemotherapy with 5-FU we investigated the concentration of 5-FU in the rabbit portal vein by HPLC and evaluated the inhibitory effect on the growth of H22 ascitic tumor and the sensitivity of H22 cells to 5-FU in the mouse models.从家兔门静脉血中5-FU的浓度变化，H22腹水瘤小鼠的治疗疗效以及H22细胞对5-FU的化疗敏感性等多方面探讨腹腔内缓释化疗的优势。
6)Slow intra-tumor release of drugs瘤内缓释化疗
延伸阅读
茶碱缓释片，无水茶碱缓释片，茶碱, 埃斯玛隆药物名称：茶碱英文名：Theophylline别名：茶碱缓释片，无水茶碱缓释片，茶碱, 埃斯玛隆；葆乐辉；时乐平；舒弗美 ，优喘平，长效茶喘平外文名：Theophylline Sustained Release Tablets(茶碱缓释片),Anhydrous Theophylline Sustained Tablets(无水茶碱缓释片),ASMALON, Elixophylline, Etrafon, Theo-Dur, PROTHEO成分： 茶碱 适应症： 支气管哮喘以及伴有慢性支气管炎和肺气肿的可逆性支气管痉挛，对夜间发作的哮喘患者更适宜。 用量用法： 成人 一般剂量为200mg/日，晚上8－9点服用或早晚各服用100mg,根据病情可增加剂量至最大用量600mg/日，3岁以上儿童10mg/kg体重／日。 禁忌： 对茶碱不能耐受的病人，未治愈的癫痫患者。 不良反应： 头痛、恶心、失眠，少见消化不良、震颤和眩晕。 注意事项： 消化性溃疡，肝肾功能不全，心力衰竭，持续高烧及使用某些药物，有低氧血症，高血压病史的患者慎用。孕妇及哺乳妇女避免使用。茶碱的毒性常出现在血清浓度为１５～２０μｇ／ｍｌ，特别是在治疗开始，早期多见的有恶心、呕吐、易激动、失眠等，当血清浓度超过２０μｇ／ｍｌ，可出现心动过速、心律失常，血清中茶碱超过４０μｇ／ｍｌ，可发生发热、失水、惊厥等症状，严重的甚至呼吸、心跳停止致死。本品可通过胎盘屏障，也能分泌入乳汁，随乳汁排出，故孕妇、产妇及哺乳期妇女慎用。新生儿血浆清除率可降低，血清浓度增加，应慎用。老年人因血浆清除率降低，潜在毒性增加，５５岁以上患者慎用。 药物相互作用： 与别嘌呤醇，西咪替丁，环丙沙星，红霉素及口服避孕药合用，可使茶碱血浓度增加。与利福平合用时，可使血清浓度降低。与苯妥因合用时，二者血药浓度均降低。勿与非选择性β－受体阻滞剂同时使用。 规格： 胶囊 50 mg x 10粒。100 mg x 10粒。200mg x 10粒。 类别：平喘药\磷酸二酯酶抑制药
